HHS plans new FDA deputy commissioner roles for technology and drugs, sources say
The U.S. Department of Health and Human Services (HHS) is planning to create two new deputy commissioner roles at the FDA.
4 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 4 separate news trends connected to Healthcare Regulation, spanning July 12, 2026 through August 25, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 27 article observations and 27 source signals, led by Business coverage. Use it to compare how individual events emerged, spread and changed over time.
The U.S. Department of Health and Human Services (HHS) is planning to create two new deputy commissioner roles at the FDA.
The FDA has approved 1,500 AI medical devices, sparking debate on whether autonomous AI can outperform AI-assisted physicians.
An FDA advisory panel has voted in favor of easing access to peptides, signaling a potential shift in regulatory policy for the substances.
Legal battles and legislative efforts are intensifying as lawmakers and courts challenge the power of health insurance giants and pharmacy benefit managers.